Comparative risk of epilepsy with SGLT2 inhibitors versus incretin-based therapies in type 2 diabetes.

Yen FS, Yen YH, Hung YM, Wei JC, Sung CY, Huang YH, Tsai FJ, Hwu CM, Hsu CC

DOI: 10.1002/epi.70369
Published: 2026 Jul 3
Container: Epilepsia
Publisher: Not recorded
Open access: unknown

Credibility signals

limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

cautionDOI registered: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
cautionDOI resolves: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredOpen access status: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.1002/epi.70369,
  title = {Comparative risk of epilepsy with SGLT2 inhibitors versus incretin-based therapies in type 2 diabetes.},
  author = {Yen FS and Yen YH and Hung YM and Wei JC and Sung CY and Huang YH and Tsai FJ and Hwu CM and Hsu CC},
  year = {2026},
  journal = {Epilepsia},
  doi = {10.1002/epi.70369},
  url = {https://doi.org/10.1002/epi.70369}
}

RIS

TY  - JOUR
TI  - Comparative risk of epilepsy with SGLT2 inhibitors versus incretin-based therapies in type 2 diabetes.
AU  - Yen FS
AU  - Yen YH
AU  - Hung YM
AU  - Wei JC
AU  - Sung CY
AU  - Huang YH
AU  - Tsai FJ
AU  - Hwu CM
AU  - Hsu CC
PY  - 2026
JO  - Epilepsia
DO  - 10.1002/epi.70369
UR  - https://doi.org/10.1002/epi.70369
ER  -

APA

FS, Y., YH, Y., YM, H., JC, W., CY, S., YH, H., FJ, T., CM, H., & CC, H. (2026). Comparative risk of epilepsy with SGLT2 inhibitors versus incretin-based therapies in type 2 diabetes.. Epilepsia. https://doi.org/10.1002/epi.70369

Source records

pubmed · retrieved 2026-09-27T08:29:42.457Z